Afternoon review of Hong Kong stock market

Topic 596 news 13784 Subscribers

Hong Kong market overview | The decline in Hong Kong stocks continues, with the tech index dropping over 3%; technology, real estate, and pharmaceutical outsourcing stocks are performing poorly, with wuxi apptec falling over 8% and jd.com declining nearly

Futu News · Nov 14 16:25

富途资讯11月14日消息，港股持续走低，三大指数午后跌幅扩大，恒指跌近2%，科指、国指分别痛失两大整数关口，科指跌超3%，失守4500点，国指跌超2%，失守7000点。

截至收盘，港股上涨464只，下跌1504只，收平1114只。

具体行业表现如下图：

板块方面，科网股表现萎靡，京东集团-SW跌4.72%，快手-W跌3.85%，小米集团-W跌3.63%，美团-W跌3.48%，阿里巴巴-W跌2.87%，网易-S跌0.91%，腾讯控股跌0.10%，商汤-W跌0.00%。

医疗外包概念股齐跌，药明康德跌超8%，昭衍新药跌近8%，泰格医药跌近6%，药明生物跌近6%，康龙化成跌近5%，凯莱英跌超4%。

内房股下挫，华润置地跌近4%，中国海外发展跌近4%，万科企业跌超5%，龙湖集团跌超7%，建发国际集团跌超5%，融创中国跌超7%。

加密货币概念股走强，博雅互动涨超5%，欧科云链涨近4%，美图公司涨超5%。

有色金属股走弱，赣锋锂业跌9.09%，中国宏桥跌6.72%，天齐锂业跌6.04%，中国铝业跌5.25%，洛阳钼业跌4.56%，紫金矿业跌3.74%，招金矿业跌3.50%，山东黄金跌3.08%。

苹果概念股多股下行，富智康集团跌11.83%，丘钛科技跌6.06%，瑞声科技跌5.15%，通达集团跌4.49%，比亚迪电子跌4.39%，高伟电子跌4.32%，舜宇光学科技跌4.21%。

锂电池股多股下行，赣锋锂业跌9.09%，天齐锂业跌6.04%，比亚迪电子跌4.39%，比亚迪股份跌3.35%，天能动力跌2.88%，中创新航跌2.43%，超威动力跌1.36%。

个股方面，$中国中免 (01880.HK)$跌近5%，三季度核心财务数据承压，机构看好出境游开放后口岸免税修复。

$华润饮料 (02460.HK)$跌超6%，九成收入来自“怡宝”，水企包装水价格战猛烈。

$博雅互动 (00434.HK)$ 涨超5%，比特币刷新历史纪录，加密货币概念股持续走强。

$先声药业 (02096.HK)$涨超14%，成交额突破2亿港元，公司有望迎多项催化。

$中国儒意 (00136.HK)$涨超4%，据报计划与腾讯合作中修订今明两年营业收入上限。

今日成交额TOP10

港股通资金

港股通方面，今日港股通（南向）净流入196.56亿港元。

机构观点：

麦格理：上调腾讯目标价至562港元，上调2024至26财年经调整每股盈测。

麦格理发表研报指， $腾讯控股 (00700.HK)$ 今年第三季度总营收按年升8%，经调整净利润为598亿元，分别超出该行及市场预期15%及11%。麦格理将腾讯2024至2026财年经调整每股盈利预测分别上调7%、10%、8%，同时预计2023至2026财年盈利复合年均增长率将为25%，将腾讯H股目标价由553港元上调至562港元，维持“跑赢大市”评级。

大摩：百度宣布AI时代来临并强调智能体是其主要应用形式，维持“与大市同步”评级。

摩根士丹利发报告指，在稍前参加 $百度集团-SW (09888.HK)$ 举办的Baidu World 2024活动中，百度展示了其人工智能技术的最新进展，即不需要写代码的人工智能工具秒哒，并将智能体定位为人工智能应用的主要形式，其致力于支援创建数百万个“超级有用”的应用程序，而不是创建单个“超级应用”。该行维持百度美股目标价105美元及“与大市同步”评级不变。

高盛：阿里健康上半年经调整纯利超预期，予目标价4.4港元。

高盛发表研究报告指， $阿里健康 (00241.HK)$ 9月底止中期收入按年升10%至143亿元，稍低过预期，经调整纯利达9.78亿元，胜该行及市场预期，净利润率6.8%。该行料投资者会关注公司近期的商品成交金额增长、对下半财年收入及盈利的指引、毛利扩张的潜力及中长期目标、行业动态、医保报销的政策更新，以及2025年的资本分配策略。该行对公司目标价为4.4港元，评级“买入”。

编辑/Wade

On November 14, Futu News reported that Hong Kong stocks continued to decline, with the three major indices losing ground in the afternoon. The Hang Seng Index fell nearly 2%, the Tech Index and the National Index lost two major thresholds, with the Tech Index down over 3%, falling below 4500 points, and the National Index down over 2%, falling below 7000 points.

By the close, 464 Hong Kong stocks rose, 1504 fell, and 1114 were flat.

The specific industry performance is shown in the following figure:

In the sector, the network technology stocks performed poorly, with jd.com down 4.72%, Kuaishou down 3.85%, Xiaomi down 3.63%, Meituan down 3.48%, alibaba down 2.87%, netease down 0.91%, tencent down 0.10%, and SenseTime down 0.00%.

Medical outsourcing concept stocks all fell, with wuxi apptec falling over 8%, joinn laboratories falling nearly 8%, tigermed down nearly 6%, wuxi bio down nearly 6%, pharmaron down nearly 5%, and asymchem laboratories down over 4%.

Mainland real estate stocks declined, with china res land down nearly 4%, china overseas down nearly 4%, china vanke down over 5%, longfor group down over 7%, c&d intl group down over 5%, and sunac down over 7%.

Cryptos concept stocks strengthened, with boyaa rising over 5%, okg tech rising nearly 4%, and meitu rising over 5%.

Nonferrous metals stocks weakened, with ganfenglithium down 9.09%, chinahongqiao down 6.72%, tianqi lithium corporation down 6.04%, aluminum corporation of china down 5.25%, cmoc group limited down 4.56%, zijin mining group down 3.74%, zhaojin mining down 3.50%, and sd gold down 3.08%.

Apple supplier stocks declined, fih fell by 11.83%, q tech fell by 6.06%, aac tech fell by 5.15%, tongda group fell by 4.49%, byd electronics fell by 4.39%, cowell fell by 4.32%, sunny optical fell by 4.21%.

Lithium battery stocks declined, ganfenglithium fell by 9.09%, tianqi lithium corporation fell by 6.04%, byd electronics fell by 4.39%, byd stock fell by 3.35%, tianneng power fell by 2.88%, zhongxin innovation fell by 2.43%, chaowei power fell by 1.36%.

In terms of individual stocks,$CTG DUTY-FREE (01880.HK)$Fell nearly 5%, third-quarter core financial data under pressure, institutions are bullish on the recovery of duty-free at ports after the opening of outbound tourism.

$CR BEVERAGE (02460.HK)$Fell over 6%, with 90% of revenue coming from "Yibao", the water packaging industry is in a fierce price war.

$BOYAA (00434.HK)$ Bitcoin rises over 5%, setting a new historical record, while the cryptos concept stocks continue to strengthen.

$SIMCERE PHARMA (02096.HK)$Rising over 14%, with transaction volume exceeding 0.2 billion Hong Kong dollars, the company is expected to welcome multiple catalysts.

$CHINA RUYI (00136.HK)$Rising over 4%, reported plans to revise the operating income limit for this year and next in collaboration with Tencent.

TOP 10 trading volume today

Hong Kong Stock Connect Fund

In terms of Stock Connect, today’s net inflow from the Hong Kong Stock Connect (southbound) is 19.656 billion Hong Kong dollars.

Institutional perspective:

Macquarie: Raised the target price of Tencent to 562 HKD, and raised the adjusted earnings per share estimates for the fiscal years 2024 to 2026.

Macquarie released a research report stating, $TENCENT (00700.HK)$ Total revenue in the third quarter this year increased by 8% year-on-year, with adjusted net income of 59.8 billion yuan, exceeding both the bank and market expectations by 15% and 11% respectively. Macquarie raised the adjusted earnings per share forecast for Tencent for the fiscal years 2024 to 2026 by 7%, 10%, and 8% respectively, and expects a compound annual growth rate of earnings of 25% from 2023 to 2026. The target price for Tencent's H shares has been raised from 553 HKD to 562 HKD, maintaining an 'outperform' rating.

Morgan Stanley: Baidu announced the arrival of the AI era and emphasized that intelligent agents are its main application form, maintaining a 'market perform' rating.

Morgan Stanley issued a report stating that, earlier, they participated in $BIDU-SW (09888.HK)$ At the Baidu World 2024 event, Baidu showcased the latest advancements in its AI technology, namely the no-code AI tool, Miaoda, and positioned intelligent agents as the main form of AI applications, dedicated to supporting the creation of millions of "super useful" applications, rather than a single "super app." The firm maintains a target price of $105 for Baidu's US-listed shares and has kept the rating at "in line with the market."

Goldman Sachs: Ali Health's adjusted net income exceeded expectations in the first half of the year, giving it a target price of HKD 4.4.

Goldman Sachs published a research report stating, $ALI HEALTH (00241.HK)$ Revenue for the six months ending in September rose 10% year-on-year to 14.3 billion yuan, slightly below expectations, with adjusted net income reaching 0.978 billion yuan, outperforming both the firm and market expectations, with a net income margin of 6.8%. The firm expects investors to focus on the recent growth in the company's commodity transaction amounts, guidance on revenue and earnings for the second half of the fiscal year, the potential for gross margin expansion, mid- to long-term targets, industry dynamics, policy updates on medical insurance reimbursements, and the capital allocation strategy for 2025. The firm sets a target price of HKD 4.4 for the company and maintains a "buy" rating.

编辑/Wade

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.